1. 2010 A genetic variant in RASSF1A, a key regulator of HIPPO pathway, predicts survival in two independent cohorts of mCRC patients treated with cetuximab-based chemotherapy. (September 2015) Authors: Sebio, A.; Stintzing, S.; Heinemann, V.; Zhang, W.; Sunakawa, Y.; Ichikawa, W.; Tsuji, A.; Takahashi, T.; Parekh, A.; Yang, D.; Cao, S.; Ning, Y.; Stremitzer, S.; Matsusaka, S.; Okazak, S.; Barzi, A.; Lenz, H.J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗